Regulatory Process. SMI shall provide Aspect with an advance copy of any regulatory filing relating to the Modules and Aspect shall have the right to make comments and suggestions on any such regulatory filing, provided that SMI shall only be required to provide portions of such filings describing or relating to the Bispectral Index. Any comments or suggestions made by Aspect shall be given due consideration by SMI in its discretion and changes to the regulatory filings specifically requested by Aspect shall not be unreasonably refused. Aspect agrees to promptly provide such comments (in any event within thirty (30) days of its receipt of the proposed filing), and agrees that such filings shall be the Proprietary Information of SMI.
Appears in 2 contracts
Sources: Distribution and License Agreement (Aspect Medical Systems Inc), Distribution and License Agreement (Aspect Medical Systems Inc)